The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Negative Regulation of Soluble Flt-1 and Soluble Endoglin Release by Heme Oxygenase-1
Open accessAbstract
Background— Preeclampsia is characterized clinically by hypertension and proteinuria. Soluble Flt-1 (sFlt-1; also known as soluble vascular endothelial growth factor receptor-1 [VEGFR-1]) and soluble endoglin (sEng) are elevated in preeclampsia, and their administration to pregnant rats elicits preeclampsia-like symptoms. Heme oxygenase-1 (HO-1) and its metabolite carbon monoxide (CO) exert protective effects against oxidative stimuli. Thus, we hypothesized that HO-1 upregulation may offer protection against preeclampsia by inhibiting sFlt-1 and sEng release. Methods and Results— Preeclamptic villous explants secreted high levels of sFlt-1 and sEng. Adenoviral overexpression of HO-1 in endothelial cells inhibited VEGF-mediated sFlt-1 release and interferon-γ– and tumor necrosis factor-α–induced sEng release, whereas HO-1 inhibition potentiated sFlt-1 and sEng production from endothelial cells and placental villous explants. Consistent with these findings, mice lacking HO-1 produced higher levels of sFlt-1 and sEng compared with wild-type mice. Using selective ligands (VEGF-E and placental growth factor) and a receptor-specific inhibitor (SU-1498), we demonstrated that VEGF-induced sFlt-1 release was VEGFR-2 dependent. Furthermore, CO–releasing molecule-2 (CORM-2) or CO decreased sFlt-1 release and inhibited VEGFR-2 phosphorylation. Treatment of endothelial cells with statins upregulated HO-1 and inhibited the release of sFlt-1, whereas vitamins C and E had no effect. Conclusions— The present study demonstrates that the HO-1/CO pathway inhibits sFlt-1 and sEng release, providing compelling evidence for a protective role of HO-1 in pregnancy, and identifies HO-1 as a novel target for the treatment of preeclampsia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Latest Advances in Understanding Preeclampsia
Redman, C. W., & Sargent, I. L. (2005) · Science · doi:10.1126/science.1111726 · Cited by 2,607
Soluble endoglin contributes to the pathogenesis of preeclampsia
Venkatesha, S., Toporsian, M., Lam, C., Hanai, J.-I., Mammoto, T., Kim, Y. M., Bdolah, Y., Lim, K.-H., Yuan, H.-T., Libermann, T. A., et al. (2006) · Nature Medicine · doi:10.1038/nm1429 · Cited by 1,855
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
Levine, R. J., Lam, C., Qian, C., Yu, K. F., Maynard, S. E., Sachs, B. P., Sibai, B. M., Epstein, F. H., Romero, R., Thadhani, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055352 · Cited by 1,802
Tenhunen, R., Marver, H. S., & Schmid, R. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63477-5 · Cited by 1,357
Reduced stress defense in heme oxygenase 1-deficient cells
Poss, K. D., & Tonegawa, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10925 · Cited by 1,291
Keyse, S. M., & Tyrrell, R. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.1.99 · Cited by 1,264
McConnell, J. M. L., Shelley, P., Heales, S., John, C., Jensen, R. I., Khan, I. Y., Taylor, P. D., & Poston, L. (2005) · Cited by 1,235
SIBAI, B., DEKKER, G., & KUPFERMINC, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71003-5 · Cited by 1,089
Heme oxygenase 1 is required for mammalian iron reutilization
Poss, K. D., & Tonegawa, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10919 · Cited by 1,016
Carbon Monoxide-Releasing Molecules: Characterization of Biochemical and Vascular Activities
Motterlini, R., Clark, J. E., Foresti, R., Sarathchandra, P., Mann, B. E., & Green, C. J. (2002) · Circulation Research · doi:10.1161/hh0202.104530 · Cited by 998
Smith, G. C., Pell, J. P., & Walsh, D. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05112-6 · Cited by 982
Poston, L., Briley, A., Seed, P., Kelly, F., & Shennan, A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68433-x · Cited by 760
Zhou, Y., McMaster, M., Woo, K., Janatpour, M., Perry, J., Karpanen, T., Alitalo, K., Damsky, C., & Fisher, S. J. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62567-9 · Cited by 640
Sugimoto, H., Hamano, Y., Charytan, D., Cosgrove, D., Kieran, M., Sudhakar, A., & Kalluri, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300012200 · Cited by 538
Heme oxygenase-1 protects against vascular constriction and proliferation
Duckers, H. J., Boehm, M., True, A. L., Yet, S.-F., San, H., Park, J. L., Clinton Webb, R., Lee, M.-E., Nabel, G. J., & Nabel, E. G. (2001) · Nature Medicine · doi:10.1038/89068 · Cited by 525
Ahmad, S., & Ahmed, A. (2004) · Circulation Research · doi:10.1161/01.res.0000147365.86159.f5 · Cited by 517
Self-citationOtterbein, L. E., Kolls, J. K., Mantell, L. L., Cook, J. L., Alam, J., & Choi, A. M. K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5342 · Cited by 492
Vitamins C and E and the Risks of Preeclampsia and Perinatal Complications
Rumbold, A. R., Crowther, C. A., Haslam, R. R., Dekker, G. A., & Robinson, J. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054186 · Cited by 472
Koga, K., Osuga, Y., Yoshino, O., Hirota, Y., Ruimeng, X., Hirata, T., Takeda, S., Yano, T., Tsutsumi, O., & Taketani, Y. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021942 · Cited by 403
Chaiworapongsa, T., Romero, R., Kim, Y. M., Kim, G. J., Kim, M. R., Espinoza, J., Bujold, E., Gonçalves, L., Gomez, R., Edwin, S., et al. (2005) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050400028816 · Cited by 359
Ahmed, A., Dunk, C., Ahmad, S., & Khaliq, A. (2000) · Placenta · doi:10.1053/plac.1999.0524 · Cited by 349
Self-citationUrinary Placental Growth Factor and Risk of Preeclampsia
Levine, R. J. (2005) · JAMA · doi:10.1001/jama.293.1.77 · Cited by 339
Melo, L. G., Agrawal, R., Zhang, L., Rezvani, M., Mangi, A. A., Ehsan, A., Griese, D. P., Dell’Acqua, G., Mann, M. J., Oyama, J., et al. (2002) · Circulation · doi:10.1161/hc0502.103363 · Cited by 303
Bussolati, B., Dunk, C., Grohman, M., Kontos, C. D., Mason, J., & Ahmed, A. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61775-0 · Cited by 284
Self-citationPre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy?
RODIE, V (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.01.038 · Cited by 275
Insulin Resistance and Its Potential Role in Pregnancy-Induced Hypertension
Seely, E. W., & Solomon, C. G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030241 · Cited by 268
Simvastatin Induces Heme Oxygenase-1: A Novel Mechanism of Vessel Protection
Lee, T.-S., Chang, C.-C., Zhu, Y., & Shyy, J. Y.-J. (2004) · Circulation · doi:10.1161/01.cir.0000140694.67251.9c · Cited by 266
Bach1 Functions as a Hypoxia-inducible Repressor for the Heme Oxygenase-1 Gene in Human Cells
Kitamuro, T., Takahashi, K., Ogawa, K., Udono-Fujimori, R., Takeda, K., Furuyama, K., Nakayama, M., Sun, J., Fujita, H., Hida, W., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209939200 · Cited by 262
Crispi, F., Domínguez, C., Llurba, E., Martín-Gallán, P., Cabero, L., & Gratacós, E. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.01.014 · Cited by 252
Kweon, M.-H., Adhami, V. M., Lee, J.-S., & Mukhtar, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604748200 · Cited by 250
Zhang, X., Shan, P., Jiang, D., Noble, P. W., Abraham, N. G., Kappas, A., & Lee, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312941200 · Cited by 241
Release and Complex Formation of Soluble VEGFR-1 from Endothelial Cells and Biological Fluids
Hornig, C., Barleon, B., Ahmad, S., Vuorela, P., Ahmed, A., & Weich, H. A. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780050 · Cited by 223
Self-citationCarbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1–dependent pathway
Hegazi, R. A. F., Rao, K. N., Mayle, A., Sepulveda, A. R., Otterbein, L. E., & Plevy, S. E. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051047 · Cited by 217
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
Levine, R. J., Lam, C., Qian, C., Yu, K. F., Maynard, S. E., Sachs, B. P., Sibai, B. M., Epstein, F. H., Romero, R., Thadhani, R., et al. (2007) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000253489.32189.4d · Cited by 216
Hung, T.-H., Charnock-Jones, D. S., Skepper, J. N., & Burton, G. J. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63192-6 · Cited by 210
Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia
BAKER, P., KRASNOW, J., ROBERTS, J., & YEO, K. (1995) · Obstetrics & Gynecology · doi:10.1016/0029-7844(95)00259-t · Cited by 207
Maternal Serum sFlt1 Concentration Is an Early and Reliable Predictive Marker of Preeclampsia
Hertig, A., Berkane, N., Lefevre, G., Toumi, K., Marti, H.-P., Capeau, J., Uzan, S., & Rondeau, E. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.036715 · Cited by 188
Maines, M. D., Mayer, R. D., Ewing, J. F., & McCoubrey, W. K. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10290-5 · Cited by 182
Adverse pregnancy outcomes in snuff users
England, L. J., Levine, R. J., Mills, J. L., Klebanoff, M. A., Yu, K. F., & Cnattingius, S. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/s0002-9378(03)00661-6 · Cited by 174
The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells
Grosser, N., Hemmerle, A., Berndt, G., Erdmann, K., Hinkelmann, U., Schürger, S., Wijayanti, N., Immenschuh, S., & Schröder, H. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.09.009 · Cited by 161
Ahmed, A., Rahman, M. M., Zhang, X., Acevedo, C. H., Nijjar, S. S., Rushton, I., Bussolati, B., & John, J. C. S. (2000) · Molecular Medicine · doi:10.1007/bf03401783 · Cited by 152
Self-citationAhmad, S., Hewett, P. W., Wang, P., Al‐Ani, B., Cudmore, M., Fujisawa, T., Haigh, J. J., le Noble, F. A. C., Wang, X., Mukhopadhyay, D., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000243989.46006.b9 · Cited by 140
Self-citationWilczyński, J. R., Tchórzewski, H., Banasik, M., Głowacka, E., Wieczorek, A., Lewkowicz, P., Malinowski, A., Szpakowski, M., & Wilczyński, J. (2002) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(02)00350-0 · Cited by 139
Vatten, L. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02718-7 · Cited by 134
Powers, R. W., Roberts, J. M., Cooper, K. M., Gallaher, M. J., Frank, M. P., Harger, G. F., & Ness, R. B. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.11.038 · Cited by 131
BARBER, A., Robson, S. C., Myatt, L., Bulmer, J. N., & Lyall, F. (2001) · The FASEB Journal · doi:10.1096/fj.00-0376com · Cited by 125
Pregnancy outcomes after maternal exposure to simvastatin and lovastatin
Pollack, P. S., Shields, K. E., Burnett, D. M., Osborne, M. J., Cunningham, M. L., & Stepanavage, M. E. (2005) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20181 · Cited by 112
Minsker, D. H., MacDonald, J. S., Robertson, R. T., & Bokelman, D. L. (1983) · Teratology · doi:10.1002/tera.1420280316 · Cited by 107
Maternal Cytokine Production Patterns in Women with Pre‐eclampsia
Azizieh, F. Y., Raghupathy, R., & Makhseed, M. (2005) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2005.00278.x · Cited by 100
Zenclussen, A. C., Fest, S., Joachim, R., Klapp, B. F., & Arck, P. (2004) · European Journal of Immunology · doi:10.1002/eji.200324469 · Cited by 95
Bainbridge, S. A., & Smith, G. N. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.11.002 · Cited by 95
Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy
Manson, J. M., Freyssinges, C., Ducrocq, M. B., & Stephenson, W. P. (1996) · Reproductive Toxicology · doi:10.1016/s0890-6238(96)00130-x · Cited by 91
Heme Oxygenases in Pregnancy II: HO‐2 is Downregulated in Human Pathologic Pregnancies
Zenclussen, A. C., Lim, E., Knoeller, S., Knackstedt, M., Hertwig, K., Hagen, E. H., Klapp, B. F., & Arck, P. (2003) · American Journal of Reproductive Immunology · doi:10.1034/j.1600-0897.2003.00047.x · Cited by 90
Banerjee, S., Smallwood, A., Moorhead, J., Chambers, A., Papageorghiou, A. T., Campbell, S. C., & Nicolaides, K. H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1113 · Cited by 88
A novel strategy against ischemia and reperfusion injury: cytoprotection with heme oxygenase system
Katori, M., Anselmo, D. M., Busuttil, R. W., & Kupiec‐Weglinski, J. W. (2002) · Transplant Immunology · doi:10.1016/s0966-3274(02)00043-6 · Cited by 86
Angiogenic Factors in the Pathogenesis of Preeclampsia
Yuan, H., Haig, D., & Karumanchi, S. A. (2005) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(05)71009-7 · Cited by 78
Bainbridge, S. A., Belkacemi, L., Dickinson, M. A., Graham, C. H., & Smith, G. N. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060184 · Cited by 74
End-tidal carbon monoxide measurements in women with pregnancy-induced hypertension and preeclampsia
Baum, M., Schiff, E., Kreiser, D., Dennery, P. A., Stevenson, D. K., Rosenthal, T., & Seidman, D. S. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.109047 · Cited by 71
Smith, G. C., Comrie, M., Wolf, C. R., Dawe, R. S., Clark, C., Evans, A. T., Ferguson, J., & Ibbotson, S. H. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12354.x · Cited by 61
Basal Rather Than Induced Heme Oxygenase-1 Levels Are Crucial in the Antioxidant Cytoprotection
Tsuchihashi, S.-I., Livhits, M. J., Zhai, Y., Busuttil, R. W., Araujo, J. A., & Kupiec‐Weglinski, J. W. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4749 · Cited by 60
Kodama, Y., Kitta, Y., Nakamura, T., Takano, H., Umetani, K., Fujioka, D., Saitō, Y., Kawabata, K., Obata, J., Mende, A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.035 · Cited by 53
Relation Between Adenosine and T-helper 1/T-helper 2 Imbalance in Women With Preeclampsia
Yoneyama, Y., Suzuki, S., Sawa, R., Yoneyama, K., Power, G. G., & Araki, T. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)01657-5 · Cited by 45
Lash, G. E., McLaughlin, B. E., Macdonald-Goodfellow, S. K., et al. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00738.2002 · Cited by 45
Urinary cotinine concentration confirms the reduced risk of preeclampsia with tobacco exposure
Lain, K. Y., Powers, R. W., Krohn, M. A., Ness, R. B., Crombleholme, W. R., & Roberts, J. M. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70107-9 · Cited by 44
Heparin-binding angiogenic growth factors in pregnancy
Ahmed, A. (1997) · Placenta · doi:10.1016/s0143-4004(97)80091-4 · Cited by 41
Self-citationHeparin suppresses sgk, an early response gene in proliferating vascular smooth muscle cells
Delmolino, L. M., & Castellot, J. J. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199712)173:3<335::aid-jcp5>3.0.co;2-o · Cited by 40
Statin drugs and congenital anomalies
Gibb, H. J., & Scialli, A. R. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30685 · Cited by 32
Newby, D., Cousins, F., Myatt, L., & Lyall, F. (2004) · Placenta · doi:10.1016/j.placenta.2004.05.002 · Cited by 21
End-tidal Breath Carbon Monoxide Measurements are Lower in Pregnant Women with Uterine Contractions
Hendler, I., Baum, M., Kreiser, D., Schiff, E., Druzin, M. L., Stevenson, D. K., & Seidman, D. S. (2004) · Journal of Perinatology · doi:10.1038/sj.jp.7211094 · Cited by 6
Cited by
Rana (2019) · doi:10.1161/circresaha.118.313276 · Cited by 2,095
Pre-eclampsia: pathogenesis, novel diagnostics and therapies
Phipps, E. A., Thadhani, R., Benzing, T., & Karumanchi, S. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0119-6 · Cited by 1,191
Powe, C. E., Levine, R. J., & Karumanchi, S. A. (2011) · Circulation · doi:10.1161/circulationaha.109.853127 · Cited by 967
Extracellular control of TGFβ signalling in vascular development and disease
ten Dijke, P., & Arthur, H. M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2262 · Cited by 778
Young, B. C., Levine, R. J., & Karumanchi, S. A. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102149 · Cited by 719
Metadata
- Authors
- Cudmore, M., Ahmad, S., Al-Ani, B., Fujisawa, T., Coxall, H., Chudasama, K., Devey, L. R., Wigmore, S. J., Abbas, A., Hewett, P. W., & Ahmed, A.
- Venue
- Circulation
- Published
- 2007-04-03
- Volume
- 115
- Issue
- 13
- Pages
- 1789-1797
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2093772580
- Cited by
- 421
- References
- 73
- FWCI
- 28.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.